Write in a clean editor, then format for Frontiers in Drug Safety and Regulation in one click — DocuGuru applies the official Frontiers template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Frontiers in Drug Safety and Regulation is a peer-reviewed journal published by Frontiers, covering Pharmacovigilance and Adverse Drug Reactions, Health Systems, Economic Evaluations, Quality of Life, Biosimilars and Bioanalytical Methods. Over its lifetime it has published 115 papers, which have received 704 citations.
| Publisher | Frontiers |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Frontiers in Drug Safety and Regulation, 12(3), pp. 45–58.
Formats any DOI in Frontiers in Drug Safety and Regulation style. No sign-up. |
| Publishes research in | Pharmacovigilance and Adverse Drug Reactions Health Systems, Economic Evaluations, Quality of Life Biosimilars and Bioanalytical Methods Drug-Induced Adverse Reactions Pregnancy and Medication Impact |
| ISSN | 2674-0869 |
| Citation impact (2-yr) | 4.66 |
| h-index | 11 |
| i10-index | 14 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | University of Verona |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
as a standalone approach to assess a drug-related risk and cannot replace clinical judgment in the individual patient, their role remain irreplaceable for rapid detection of rare and unpredictable adverse drug reactions with strong drug-attributable component (e.g., designated medical events), especially when developed by a multidisciplinary team and combined with a careful case-by-case analysis (individual…
Digital therapeutics (DTx) are innovative therapeutic interventions, in which the therapeutic activity is carried out by algorithms and software. They represent a new opportunity especially for the treatment of chronic pathologies associated with dysfunctional lifestyles and behaviors, where conventional drug therapy is not fully effective. DTx are highly customizable therapeutic tools, allowing a better involvement…
In the field of drug safety, causality assessment aims to determine the level of plausibility of the relationship between an adverse event and exposure to a particular product. It is after the causality assessment process that we will be able to point out a product adverse reaction. While regulators often require pharmaceutical companies to use…
The ageing process is associated with an increased probability of accumulating health deficits, chronic conditions and geriatric syndromes, leading to a growing prevalence of multimorbidity, defined as the co-occurrence of two or more chronic conditions (of which, at least one physical condition). One of the most frequent and direct consequences of multimorbidity, especially amongst older…
